At Keva Health, we understand the challenges of managing COPD. Our advanced remote patient monitoring program uses devices like pulse oximeters and spirometers to track vital signs between office visits, ensuring continuous care and timely interventions.
The platform monitors breathlessness, flare-ups, oxygen levels, medication adherence and real-time alerts, helping you gain deeper insights, act early, and support better long-term disease management from anywhere.
With Keva Health’s program, patients can manage their symptoms more proactively, with personalized insights and seamless care coordination.
With COPD monitoring on Keva365, patients record breathlessness, cough, and flare-ups daily to build a complete picture of trends over time.
Access to real-time notifications about any changes helps patients respond to issues quickly.
Keva365 allows patients to share their health data with your care team, supporting timely decisions and more personalized COPD management.
Track your spirometer readings and oxygen levels to stay on top of your lung function and detect early signs of decline.
Get access to your remote patient monitoring report, then share it with your physician to create your personalized care plan.
Patients may access the platform and get personalized tips at anytime.
Fill out this form to request more information or contact us! We can get in touch with your doctor to set up the program.
Keva365 is a Physician’s tool for COPD management and monitoring optimization in between visits.
Our HIPAA-compliant and secured SaaS platform allows you to collect patient data in between clinic visits.
Bluetooth devices (pulse oximeter and spirometer) allow patients to monitor respiratory health.
Treatment pathway decision making for patients and their stratification through workflows made easy.
Get regular reports to track patient progress, manage care between visits, and use customizable alerts to save time while delivering quality care.
Chronic Obstructive Pulmonary Disease (COPD) is a progressive condition that restricts airflow to the lungs, making it increasingly difficult to breathe. It commonly manifests as emphysema, chronic bronchitis, or a combination of both, often developing after long-term exposure to irritants such as tobacco smoke or air pollutants, which cause inflammation and permanent damage to lung tissue. COPD often presents as a persistent cough producing sputum, frequent respiratory infections, shortness of breath—especially during physical activity—along with wheezing, chest tightness, and fatigue. As the condition progresses, these issues may intensify, increasingly limiting daily activities and diminishing overall quality of life.
COPD progresses gradually, and without consistent monitoring, subtle changes can go unnoticed until a major flare-up occurs. Continuous symptom tracking, lung function monitoring, and medication adherence are critical to managing the disease effectively.
No money or other consideration is being solicited, and if sent in response, will not be accepted. No offer to buy the securities can be accepted and no part of the purchase price can be received until the offering statement is filed and only through an intermediary’s platform. An indication of interest involves no obligation or commitment of any kind. “reserving” securities is simply an indication of interest.